Literature DB >> 8172599

E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions.

B J Gour-Salin1, P Lachance, M C Magny, C Plouffe, R Ménard, A C Storer.   

Abstract

A number of epoxysuccinyl amino acid benzyl esters (HO-Eps-AA-OBzl) and benzyl amides (HO-Eps-AA-NHBzl) (where AA represents amino acid) were synthesized as analogues of E64, a naturally occurring inhibitor of cysteine proteinases. These inhibitors were designed to evaluate if selectivity for cathepsin B could be achieved by varying the amino acid on the basis of known substrate specificity. Contrary to the situation with substrates, it was found that variation of the amino acid in the E64 analogues does not lead to major changes in the kinetic parameter kinac./Ki and that the specificity of these analogues does not parallel that observed for substrates. This is particularly true in the case of the benzyl ester derivatives where the deviation from substrate-like behaviour is more important than with the benzyl amide derivatives. The results suggest that the amide proton of the benzyl amide group in HO-Eps-AA-NHBzl interacts in the S2 subsite in both cathepsin B and papain and contributes to increase the potency of these inhibitors. The kinetic data also suggest that differences in the orientation of the C alpha-C beta bond of the side chain in the S2 subsite of the enzyme might explain the differences between substrate and E64 analogue specificities. This hypothesis is supported by the fact that the order of inactivation rates with chloromethane inhibitors (which are believed to be good models of enzyme-substrate interactions) is indeed very similar to that observed with the corresponding amidomethylcoumarin substrates. In conclusion, the information available from S2-P2 interactions with substrates cannot be used to enhance the selectivity of the E64 analogues in a rational manner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172599      PMCID: PMC1138284          DOI: 10.1042/bj2990389

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers.

Authors:  J O Harris; G N Olsen; J R Castle; A S Maloney
Journal:  Am Rev Respir Dis       Date:  1975-05

2.  An agarose mercurial column for the separation of mercaptopapain and nonmercaptopapain.

Authors:  L A Sluyterman; J Wijdenes
Journal:  Biochim Biophys Acta       Date:  1970-03-31

3.  Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases.

Authors:  D Johnson; J Travis
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

4.  Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo.

Authors:  S Hashida; T Towatari; E Kominami; N Katunuma
Journal:  J Biochem       Date:  1980-12       Impact factor: 3.387

Review 5.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption.

Authors:  J M Delaissé; Y Eeckhout; G Vaes
Journal:  Biochem Biophys Res Commun       Date:  1984-12-14       Impact factor: 3.575

7.  Binding of chloromethyl ketone substrate analogues to crystalline papain.

Authors:  J Drenth; K H Kalk; H M Swen
Journal:  Biochemistry       Date:  1976-08-24       Impact factor: 3.162

8.  Relaxed and perturbed substrate conformations in enzyme active sites: evidence from multichannel resonance raman spectra.

Authors:  A C Storer; H Lee; P R Carey
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

9.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

10.  Facile synthesis of amino acid and peptide esters under mild conditions via cesium salts.

Authors:  B F Gisin; D P Winter; R Makofske; I D Kulesha; C Tzougraki; J Meienhofer
Journal:  J Org Chem       Date:  1977-04-15       Impact factor: 4.354

View more
  6 in total

1.  ProPose: a docking engine based on a fully configurable protein-ligand interaction model.

Authors:  Markus H J Seifert; Frank Schmitt; Thomas Herz; Bernd Kramer
Journal:  J Mol Model       Date:  2004-10-08       Impact factor: 1.810

2.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.

Authors:  R Coulombe; P Grochulski; J Sivaraman; R Ménard; J S Mort; M Cygler
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

3.  The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.

Authors:  I M Melzer; S B M Fernández; S Bösser; K Lohrig; U Lewandrowski; D Wolters; S Kehrloesser; M-L Brezniceanu; A C Theos; P M Irusta; F Impens; K Gevaert; M Zörnig
Journal:  Cell Death Differ       Date:  2012-03-02       Impact factor: 15.828

Review 4.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

5.  Metal-conjugated affinity labels: a new concept to create enantioselective artificial metalloenzymes.

Authors:  Thomas Reiner; Dominik Jantke; Alexander N Marziale; Andreas Raba; Jörg Eppinger
Journal:  ChemistryOpen       Date:  2013-02-20       Impact factor: 2.911

6.  Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity.

Authors:  Mohamed Azarkan; Erik Maquoi; François Delbrassine; Raphael Herman; Nasiha M'Rabet; Rafaèle Calvo Esposito; Paulette Charlier; Frédéric Kerff
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.